A universal vaccine for serogroup B meningococcus INAUGURAL ARTICLE by a Recently Elected Academy Member:A universal vaccine for serogroup B meningococcus Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 NadA, a novel vaccine candidate of Neisseria meningitidis Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Outcomes of clinical simulation for novice nursing students: communication, confidence, clinical judgment NadA diversity and carriage in Neisseria meningitidis Stapled and open hemorrhoidectomy: randomized controlled trial of early results. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup ...
